Aclaris Therapeutics (ACRS) Net Margin (QoQ) (2017 - 2026)
Aclaris Therapeutics (ACRS) Net Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,157.00 |
| Dec 31, 2025 | -183,666.00 |
| Sep 30, 2025 | 47,996.00 |
| Jun 30, 2025 | 20,904.00 |
| Mar 31, 2025 | -9,506.00 |
| Dec 31, 2024 | -95,334.00 |
| Sep 30, 2024 | 19,218.00 |
| Jun 30, 2024 | 31,227.00 |
| Mar 31, 2024 | -71,612.00 |
| Dec 31, 2023 | 34,424.00 |
| Sep 30, 2023 | 173,168.00 |
| Jun 30, 2023 | -73,697.00 |
| Mar 31, 2023 | 140,029.00 |
| Dec 31, 2022 | -255,855.00 |
| Sep 30, 2022 | 191,370.00 |
| Jun 30, 2022 | 51,093.00 |
| Mar 31, 2022 | 970,522.00 |
| Dec 31, 2021 | -1.00 Mn |
| Sep 30, 2021 | -36,958.00 |
| Jun 30, 2021 | 144,566.00 |